Cambridge Advisors Inc. Ark Genomic Revolution ETF (De Transaction History
Cambridge Advisors Inc.
- $499 Million
- Q4 2025
A detailed history of Cambridge Advisors Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Cambridge Advisors Inc. holds 8,262 shares of ARKG stock, worth $222,165. This represents 0.04% of its overall portfolio holdings.
Number of Shares
8,262Holding current value
$222,165% of portfolio
0.04%Shares
19 transactions
Others Institutions Holding ARKG
# of Institutions
297Shares Held
20.5MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio